Status:
COMPLETED
Epithelioid Sarcoma Natural History Study
Lead Sponsor:
Epizyme, Inc.
Collaborating Sponsors:
Analysis Group, Inc.
Conditions:
Epithelioid Sarcoma
Eligibility:
All Genders
10+ years
Brief Summary
This study is a multi-center, non-interventional retrospective medical records review. The study will involve identification of medical records of patients with confirmed locally advanced unresectable...
Detailed Description
The sampling period will span from January 1, 2000 to December 31, 2017. As the chart abstraction dates may be different across institutions due to contracting and other logistical issues, to avoid se...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosed with histologically confirmed, locally advanced unresectable or metastatic Epithelioid Sarcoma (ES) requiring systemic therapy during between January 1, 2000 and December 31, 2017. The date of the confirmed locally advanced unresectable or metastatic ES diagnosis is designated as the index date.
- Patients may have a date of ES diagnosis at an earlier stage prior to 2000 and still be eligible for the study
- Initiation of treatment with any systemic anti-cancer therapy for the treatment of their locally advanced unresectable or metastatic ES between January 1, 2000 and December 31, 2017
- At least 10 years of age at the index date
Exclusion
Key Trial Info
Start Date :
June 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 2 2021
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT03837678
Start Date
June 4 2018
End Date
September 2 2021
Last Update
March 7 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Cancer Center
Denver, Colorado, United States, 80045
2
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215
3
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States, 48109
4
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065